The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response ; day:23 ; month:11 ; year:2021 ; extent:1
The chemical record ; (23.11.2021) (gesamt 1)
- Creator
-
Stergiou, Natascha
Urschbach, Moritz
Gabba, Adele
Schmitt, Edgar
Kunz, Horst
Besenius, Pol
- DOI
-
10.1002/tcr.202100182
- URN
-
urn:nbn:de:101:1-2021112314240178294890
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stergiou, Natascha
- Urschbach, Moritz
- Gabba, Adele
- Schmitt, Edgar
- Kunz, Horst
- Besenius, Pol
Other Objects (12)
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Synthetic carbohydrate-based vaccines: challenges and opportunities
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Synthetic carbohydrate-based vaccines: challenges and opportunities
The development of vaccines from synthetic tumor-associated mucin glycopeptides and their glycosylation-dependent immune response
B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation
High level in vivo mucin-type glycosylation in Escherichia coli
Recombinant and synthetic vaccines
A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota
Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response